32 fed-batch cultures at 28°C
Export PNG

Creators
Submitter
Views: 9 Downloads: 0
Created: 20th Oct 2025 at 14:35

This item has not yet been tagged.

None
Version History
Version 1 (earliest) Created 20th Oct 2025 at 14:35 by Susana Alonso Villela
No revision comments
Related items
Projects: Scorpion antivenom nanobody production in Escherichia coli (Recombinant bispecific VHH), Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
Institutions: INSAT - Institut National des Science Appliquees de Toulouse, INRAE

Expertise: Biotechnology, Industrial Biotechnology
Tools: Fermentation, Microbiology
Bioprocess engineer with extensive expertise in bioreactor process design, fermentation technologies, and protein production. Skilled in scaling up bioprocesses, experimental design, and process optimization.
Bioindustry 4.0 is a cutting-edge initiative perfecting advanced technologies to empower European bioindustry sector. Our overarching aim is to make the development of bioprocesses faster and cheaper, and biomanufacturing more reliable.
Projects: Scorpion antivenom nanobody production in Escherichia coli (Recombinant bispecific VHH), Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
Web page: https://www.bioindustry4.eu
Scorpionism is a serious public health problem in tropical areas, especially in Africa, southern India, the Middle East, and Latin America. There are about 12 species of scorpions that are dangerous to humans and all belong to the Buthidae family. In particular, venom on scorpion Androctonus australis hector is particularly toxic to humans. Serotherapy uses antibodies or fragments of antibodies to target the neurotoxins of the scorpion venom. Nanobodies, camelid-derived antibodies, are more ...
Organisms: Escherichia coli
We studied the production of scorpion antivenom nanobodies in high cell density microbioreactors. The BiolectorXT (Beckman) was used to screen different production strategies within the framework of a machine-learning model optimization.
Submitter: Susana Alonso Villela
Studies: Characterization of nanobody-producer strains in microbioreactors
Assays: Fed-batch culture of E. coli strains in microbioreactors
Snapshots: No snapshots
The screening of E. coli strains WK6, CH10-12 (2017), CH10-12 (2023), NbF12-10 (2017), and NbF12-10 (2023) was made in a BioLectorXT (Beckman) setting
Submitter: Susana Alonso Villela
Investigation: Scale-down effects of the nanobody producing E....
Assays: Fed-batch culture of E. coli strains in microbioreactors
Snapshots: No snapshots
Culture of E. coli strains WK6, CH10-12 (2017), CH10-12 (2023), NbF12-10 (2017), and NbF12-10 (2017) at 28°C in a fed-batch microbioreactor setting.
Submitter: Susana Alonso Villela
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Scale-down effects of the nanobody producing E....
Organisms: No organisms
SOPs: No SOPs
Data files: BiolectorXT data from the screening of E. coli ...
Snapshots: No snapshots